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Sažetak:  Cilj: Premda su ranije studije potvrdile vezu između gojaznosti i hipertenzije, 
patofiziološki mehanizam ove povezanosti još uvek nije rasvetljen, naročito što postoje oprečni rezultati 
kada je u pitanju nezavisna uloga gojaznosti i/ili insulinske rezistencije u nastanku hipertenzije. Stoga je 
cilj studije bio da se ispita da li je gojaznost [merena indeksom telesne mase (ITM)] prediktor za nastanak 
hipertenzije, nezavisno od insulinske rezistencije [merene HOMA indeksom (HOMA-IR)] u kohorti žena u 
postmenopauzi. Metode: Ukupno 150 žena u postmenopauzi koje nisu na terapiji (među njima 44,7% sa 
hipertenzijom) su uključene u studiju preseka. Antropometrijski i biohemijski parametri, kao i krvni 
pritisak su mereni. HOMA-IR je računat. Rezultati: Multivarijantna logistička regresiona analiza je 
pokazala da su i ITM (OR=1,240; p=0,035) i HOMA-IR (OR=2,419; p=0,008)nezavisni prediktori krvnog 
pritiska kod žena u postmenopauzi. Povećanje ITMza1 kg/m2 povećava verovatnoću za pojavu 
hipertenzije za 24%. Takođe, porast HOMA-IR za 1 jedinicu povećava verovatnoću za pojavu hipertenzije 
za skoro 2,5 puta. Čak 47% varijacije u vrednosti krvnog pritiska može biti objašnjeno ovim modelom. 
Takođe, ovaj model je ispravno klasifikovao 76% žena u postmenopauzi koje imaju hipertenziju. 
Zaključak: I gojaznost, i insulinska rezistencija su nezavisni prediktori krvnog pritiska kod žena u 
postmenopauzi.  
Ključne reči:  hipertenzija, insulinska rezistencija, gojaznost, žene u postmenopauzi 
 
Abstract:  Aim: Although previous studies confirmed the association between obesity and 
hypertension, the underlying pathophysiological mechanism is not well elucidated, specially considering 
the fact that discordant results exist when examining the independent role of obesity and/or insulin 
resistance on risk for hypertension onset. Therefore, we aimed to examine if obesity [as measured with 
body mass index (BMI)] is a predictor for hypertension, independently of insulin resistance [as measured 
with Homeostasis model assessment of insulin resistance (HOMA-IR)] in the cohort of postmenopausal 
women. Methods: A total of 150 postmenopausal women non-treated with medications(among them 
44.7% hypertensive)were included in cross-sectional study. Anthropometric and biochemical parameters, 
so as blood pressure were obtained. HOMA-IR was calculated. Results: Multivariate logistic regression 
analysisrevealed that both, BMI and HOMA-IR were the independent predictors of blood pressure in 
postmenopausal women (OR=1.240, p=0.035 and OR=2.419, p=0.008, respectively). Rise in BMI for 1 
kg/m2 enhanced the probability for higher blood pressure by 24%. Also, elevation in HOMA-IR for 1 unit, 
rose the probability for higher blood pressure almost 2.5 times. Even 47% of variation in blood pressure 
could be explained with this Model. Also, this Model correctly classified 76% of postmenopausal women 
having hypertension. Conclusions: Both, obesity and insulin resistance are the independent predictors of 
blood pressure in postmenopausal women. 
Keywords:  hypertension, insulin resistance, obesity, postmenopausal 
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INTRODUCTION 
 
It is well known that women experiencing 
menopause have unfavorable cardiometabolic 
profile, compared to women in reproductive age 
[1]. These changes are mostly attributable to 
hormonal disturbances, mainly due to loss of 
estrogen [2]. Therefore, it is not surprising that 
postmenopausal women had higher incidence of 
cardiometabolic disorders than premenopausal 
women [1, 3].  
It is speculated that redistribution of adipose 
tissue towards visceral region, due to hormonal 
changes may be the main pathogenic entity,  
consequently leading to increased 
cardiometabolic risk [4] in postmenopause. 
Increased visceral fat mass is a source of 
proinflammatory adipocytokines [5-8], exerting 
a low-grade inflammation environment which 
could predispose to the future hypertension 
occurrence [9]. 
In addition, increased abdominal fat mass is 
accompanied with increased insulin resistance 
[4, 8]. However, even though previous studies 
confirmed the association between obesity and 
hypertension, the underlying pathophysiological 
mechanism is not well elucidated [10, 11]. 
Especially considering the fact that discordant 
results were seen in literature when examining 
the independent role of obesity and/or insulin 
resistance on risk for hypertension occurrence 
and progression. Namely, some studies reported 
that obesity may be associated with 
hypertension incidence, acting through some 
other mechanisms, different from insulin 
signaling pathways [10, 11]. 
Having this in mind, we aimed to examine if 
obesity [as measured with body mass index 
(BMI)] has a predictive role for hypertension, 
independently of insulin resistance [as 
measured with Homeostasis model assessment 
of insulin resistance (HOMA-IR)] in the cohort of 
postmenopausal women. 
 
MATERIALS AND METHODS 
Study population 
The current cross-sectional study derived from 
our previous works investigating the utility of 
examining cardiometabolic markers in 
postmenopausal women [1-7]. 
A total of 150 postmenopausal women non-
treated with medications (among them 44.7% 
hypertensive) were included in cross-sectional 
study. All examined women were recruited by 
the gynecologist in the Center of Laboratory 
Diagnostics of the Primary Health Care Center in 
Podgorica, Montenegro, for their regular 
biochemical analyses check-up in a period from 
October 2012 to May 2013.  Women were 
considered to be postmenopausal if they 
reported the absence of menstrual bleeding for 
more than one year.  
Inclusion criteria to enter the study were: 
menopausal status, no signs and symptoms of 
acute inflammatory disease, no history of 
malignancy, non-smoking, and no any 
medicament therapy usage in the last six 
months. 
Exclusion criteria were: High sensitivity C-
reactive protein (hsCRP) >10 mg/L, diabetes 
mellitus, hypothyroidism or hyperthyroidism, 
liver disease other than steatosis, renal 
dysfunction, cardiovascular disorders, and any 
medications use in the last six months. 
All postmenopausal women signed informed 
consent. The investigation was carried out in 
compliance with the Declaration of Helsinki, and 
Ethical Committee of Primary Health Care 
Center in Podgorica, Montenegro approved the 
study protocol. 
Anthropometric measurements 
Basic anthropometric measurements were 
obtained, as described previously [4]. 
Biochemical analyses 
Biochemical parameters were measured as 
described elsewhere [4]. Serum levels of glucose, 
lipid parameters [e.g., total cholesterol (TC), high 
density lipoprotein cholesterol (HDL-c), low 
density lipoprotein cholesterol (LDL-c), 
triglycerides (TG)], bilirubin, uric 
acid,creatinine, as well as the activity of aspartat 
aminotransferase (AST), alanine 
aminotransferase (ALT) and gamma-glutamyl 
transferase (GGT), were measured 
spectrophotometrically (Roche Cobas 400, 
Mannheim, Germany). 
Levels of hsCRP were determined using an 
immunonephelometric assay (Behring 
Nephelometer Analyzer, BN II, Marburg, 
Germany). HOMA-IR was calculated, as 
described elsewhere [2]. Blood pressure was 
measured and Glomerular filtration rate was 
estimated (eGFR) as described previously [2, 3]. 
Hypertension was defined as (systolic/diastolic 
blood pressure (BP) (≥140/≥90 mmHg) [9]. 
Statistical analysis 
Statistical data of the study populations are 
presented as mean ± standard deviation for 
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normally distributed data, as geometric means 
(95% confidence interval - CI) for log-normally 
distributed data [12] and as median 
(interquartile range) for skewed distributed 
data. Distribution of data were tested by 
Kolmogorov-Smirnov statistical test. 
Comparisons of continuous normally and log-
normally distributed variables were performed 
using the Student's t-test. Comparisons of 
skewed distributed data were performed using 
Mann-Whitney U-test. Spearman's correlation 
analysis was employed to estimate possible 
associations of SBP and DBP with general and 
clinical parameters.  Binary logistic regression 
analysis was performed to assess the ability of 
demographic and clinical parameters to predict 
hypertension in postmenopausal women. 
Postmenopausal women with arterial tension 
defined as SBP ≥ 140 mmHg and DBP ≥90 mmHg 
were coded as 1 and postmenopausal women 
with arterial tension defined as SBP <140 mmHg 
and DBP <90 mmHg were coded as 0. 
Multivariate logistic regression was performed 
for Model taking into account all parameters 
(predictors) that showed significant Spearman 
bivariate correlation with SBP and DBP. In 
Model odds (OR) and 95% CI were determined 
for each parameter. The explained variation in 
blood pressurewas given by Nagelkerke R2 
coefficient of logistic regression analysis. 
Receiver operating characteristic (ROC) curve 
analysis for Model was performed to assess the 
ability of tested parameters to discriminate 
menopausal women with or without 
hypertension. Hosmer-Lemeshow rule for 
logistic models was used to test if there was a 
linear relationship between the predictor 
variables and the log-odds of the criterion 
variable (blood pressure level). The areas under 
the curve (AUC) were defined as poor (0.5 ≤ AUC 
< 0.7), satisfactory (0.7 ≤ AUC < 0.8), good (0.8 ≤ 
AUC < 0.9) and excellent (AUC ≥ 0.9) [13]. All 
statistical analyses were performed using PASW 
Statistics Version 18.0 and MedCalc version 15.8. 
All statistical tests were considered when 
probability level was less than 0.05.  
 
Results 
The general demographic characteristics of the 
two study populations are given in Table 1. 
There were statistical significant differences in 
all parameters except for menopause duration. 
Hypertensive menopausal women were older, 
had higher BMI, WC, SBP and DBP than 
normotensive menopausal women.  
 
 
Table 1. General and clinical characteristics of postmenopausal women according to blood pressure 
Tabela 1. Opšte i kliničke karakteristike ispitivanih žena u postmenopauzi podeljenih na osnovu vrednosti 
krvnog pritiska 
 
 Normotensive Hypertensive p 
N  83 67  
Age, years 55.87±4.79 57.55±4.76 0.033 
BMI, kg/m2 24.75±3.64 28.58±4.19 <0.001 
WC, cm * 85.00 (78.00-91.00) 97.00 (85.00-103.00) <0.001 
SBP, mmHg  110±17 150±13 0.005 
DBP, mmHg  75±10 96±8 0.001 
Menopausal duration, years 5.55±4.81 6.49±4.66 0.230 
 
Data are presented as arithmetic mean ± SD and 
compared with Student’s t-test. 
*Data are presented as median (interquartile 
range) and compared by Mann-Whitney U test 
BMI-Body mass index; WC-Waist circumference; 
SBP-Systolic blood pressure; DBP-Diastolic 
blood pressure 
 
A significantly higher concentration of TC, LDL-c, 
TG, glucose, insulin, HOMA-IR, creatinine, uric 
acid and hsCRP were evident in the group of 
hypertensive than in normotensive 
postmenopausal women. On the contrary, HDL-c 
concentration and eGFR were significantly lower 
in hypertensive postmenopausal women. There 
were no significant differences between 
normotensive and hypertensive women when 
AST, ALT, ALP and GGT activities, total bilirubin 
and fibrinogen concentrations were compared 
between tested groups (Table 2).  
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Table 2. Laboratory and clinical parameters of studied postmenopausal women 
Tabela 2. Laboratorijski i klinički parametri ispitivanih žena u postmenopauzi 
 
 Normotensive Hypertensive P 
TC, mmol/L 6.29±1.02 6.69±1.06 0.020 
HDL-c, mmol/L 1.80±0.44 1.56±0.35 <0.001 
LDL-c, mmol/L 4.05±0.97 4.62±1.01 0.001 
TG, mmol/L* 1.14 (1.04-1.26) 1.50 (1.36-1.67) <0.001 
Glucose, mmol/L** 5.20 (4.92-5.47) 5.40 (5.10-5.97) 0.005 
Insulin, μIU/L* 5.21 (4.73-5.75) 8.28 (7.38-9.30) <0.001 
HOMA-IR* 1.21 (1.09-1.34) 2.01 (1.78-2.28) <0.001 
AST, U/L** 18 (17-22) 17 (15-19) 0.100 
ALT, U/L** 18 (14-22) 18 (14-24) 0.647 
GGT, U/L** 11 (9-15) 12 (9-16) 0.307 
Total bilirubin, µmol/L** 7.9 (6.3-11.00) 7.30 (6.82-7.70) 0.124 
Creatinine, µmol/L** 54.00 (48.25-59.00) 58.00 (50.25-62.75) 0.038 
eGFR, mL/min/1.73m² 102.53±7.97 98.96±6.58 0.004 
Uric acid, µmol/L 242.11±58.79 286.75±63.57 <0.001 
HsCRP, mg/L* 0.79 (0.63-0.98) 1.30 (1.03-1.65) 0.002 
Fibrinogen, g/L** 3.60 (3.40-4.17) 3.90 (3.42-4.40) 0.127 
 
Data are presented as arithmetic mean ± SD and 
compared with Student’s t-test 
*Log-normal distributed data are presented as 
geometric mean (95% CI) and compared with 
Student’s t-test after logarithmic transformation 
** Skewed distributed data are presented as 
median (interquartile range) and compared with 
Mann-Whitney U test 
TC-Total cholesterol; HDL-c-High density 
lipoprotein cholesterol; LDL-c-Low density 
lipoprotein cholesterol; TG-Triglycerides; 
HOMA-IR-Homeostasis model assessment of 
insulin resistance; AST-Aspartat 
aminotransferase; ALT-Alanine 
aminotransferase; GGT-Gamma-glutamil 
transferase; eGFR-Estimated glomerular 
filtration rate; hsCRP-High-sensitivity C-reactive 
protein 
 
According to Spearman’s non-parametric 
correlation analysis significant positive 
correlations were determined between both, 
SBP and DBP, with age, BMI, WC, TC, LDL-c, TG, 
glucose, insulin, HOMA-IR, uric acid and hsCRP 
(Table 3). Significant negative correlations were 
determined between both, SBP and DBP, and 
HDL-c, AST and eGFR. 
 
 
 
Table 3. Associations between SBP, DBP and other clinical parameters 
Tabela 3. Povezanost između sistolnog, dijastolnog krvnog pritiska i kliničkih parametara 
 SBP, mmHg DBP, mmHg 
ρ p ρ p 
Age, years 0.215 0.008 0.266 0.001 
BMI, kg/m2 0.467 <0.001 0.437 <0.001 
WC, cm  0.465 <0.001 0.423 <0.001 
Menopause duration, years 0.144 0.080 0.132 0.095 
TC, mmol/L 0.195 0.017 0.354 <0.001 
HDL-c, mmol/L -0.354 <0.001 -0.363 <0.001 
LDL-c, mmol/L 0.345 <0.001 0.357 <0.001 
TG, mmol/L 0.385 <0.001 0.369 <0.001 
Glucose, mmol/L 0.314 <0.001 0.279 0.001 
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Insulin, μIU/L 0.519 <0.001 0.482 <0.001 
HOMA-IR 0.535 <0.001 0.504 <0.001 
AST, U/L -0.237 0.003 -0.197 0.016 
ALT, U/L 0.075 0.363 0.043 0.606 
GGT, U/L 0.143 0.080 0.092 0.263 
Total bilirubin, µmol/L -0.151 0.066 -0.143 0.081 
Creatinine, µmol/L 0.156 0.056 0.153 0.061 
eGFR, mL/min/1.73m² -0.259 0.001 -0.267 0.001 
Uric acid, µmol/L 0.383 <0.001 0.362 <0.001 
HsCRP, mg/L 0.284 <0.001 0.232 0.004 
Fibrinogen, g/L 0.125 0.129 0.097 0.236 
 
ρ – Spearman’s correlation coefficient  
BMI-Body mass index; WC-Waist circumference; TC-Total cholesterol; HDL-c-High density lipoprotein 
cholesterol; LDL-c-Low density lipoprotein cholesterol; TG-Triglycerides; HOMA-IR-Homeostasis model 
assessment of insulin resistance; AST-Aspartat aminotransferase; ALT-Alanine aminotransferase; GGT-
Gamma-glutamil transferase; eGFR-Estimated glomerular filtration rate; hsCRP-High-sensitivity C-
reactive protein 
 
 
 
Multivariate logistic regression analysis was 
used to establish the independent associations of 
blood pressure and tested parameters which 
showed significant correlations with SBP and 
DBP (Table 4). Those predictors were age, BMI, 
WC, TC, HDL-c, LDL-c, TG, HOMA-IR, AST, eGFR, 
uric acid, and hsCRP.Hosmer-Lemeshow rule for 
logistic models showed that there was a linear 
relationship between the predictor variables and 
the log-odds of the blood pressure levels (Chi-
squared value was 8.200, p=0.414). Although, 
glucose and insulin concentrations showed 
significant correlations with SBP and DBP, they 
were excluded from multivariate logistic 
regression analysis because they entered 
equation for HOMA-IR calculation. Adjusted ORs 
for tested parameters were shown in Table 4.  
BMI and HOMA-IR were shown to be the 
independent predictors of blood pressure in 
postmenopausal women (OR=1.240, p=0.035 
and OR=2.419, p=0.008, respectively). Rise in 
BMI for 1 kg/m2 enhanced the probability for 
higher blood pressure by 24%.  Also, elevation in 
HOMA-IR for 1 unit, rose the probability for 
higher blood pressure almost 2.5 times. Adjusted 
Nagelkerke R2 coefficient for the Model was 
0.470, which means that 47% of variation in 
blood pressure could be explained with this 
Model. Also, this Model correctly classified 76% 
of postmenopausal women having hypertension.  
 
 
Table 4. Odds ratios (OR) after multivariate logistic regression analysis for parameters predicting abilities 
towards blood pressure 
Tabela 4. Statistička verovatnoća nakon multivarijantne logističke regresione analize za predikciju krvnog 
pritiska 
Predictors Adjusted 
OR (95%CI) 
p 
Age, years 1.224 (1.025-1.461) 0.102 
BMI, kg/m2 1.240 (1.015-1.515) 0.035 
WC, cm  0.922 (0.851-1.012) 0.080 
TC, mmol/L 0.543 (0.099-2.981) 0.483 
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HDL-c, mmol/L 0.525 (0.069-3.995) 0.534 
LDL-c, mmol/L 2.707 (0.489-14.991) 0.254 
TG, mmol/L 1.175 (0.463-2.980) 0.753 
HOMA-IR 2.419 (1.266-4.623) 0.008 
AST, U/L 0.865 (0.700-1.095) 0.275 
eGFR,mL/min/1.73m²  1.014 (0.942-1.091) 0.716 
Uric acid, µmol/L 1.008 (0.999-1.017) 0.072 
HsCRP, mg/L 1.136 (0.861-1.500) 0.367 
BMI-Body mass index; WC-Waist circumference; TC-Total cholesterol; HDL-c-High density lipoprotein 
cholesterol; LDL-c-Low density lipoprotein cholesterol; TG-Triglycerides; HOMA-IR-Homeostasis model 
assessment of insulin resistance; AST-Aspartate aminotransferase; eGFR-Estimated glomerular filtration 
rate; hsCRP-High-sensitivity C-reactive protein 
 
ROC analysis was used to discriminate postmenopausal women with hypertension from normotensive 
ones. When the Model tested in multivariate logistic regression analysis was used in ROC analysis, the 
clinical accuracy for diagnostic procedure was good (AUC=0.853; 95%CI 0.787-0.906; SE= 0.030). As well, 
this diagnostic procedure had sensitivity of 83.6% and specificity of 74.7% (Figure 1). 
 
Figure 1. ROC curve of Model discriminating ability between normotensive and hypertensive 
postmenopausal women 
Slika 1. ROC kriva Modela za sposobnost diskriminacije između normotenzivnih i hipertenzivnih žena u 
postmenopauzi 
 
 
Discussion 
Our study demonstrated that non-treated 
hypertensive postmenopausal women had 
higher anthropometric indices (Table 1), 
unfavorable lipid profile and HOMA-IR, as well 
as higher inflammation level (Table 2) as 
compared with normotensive counterparts. In 
addition, those women displayed higher uric 
acid level and lower level of eGFR (Table 2). 
However, multivariate logistic regression 
analysisrevealed that both, BMI and HOMA-IR 
were the independent predictors of blood 
pressure in postmenopausal women (OR=1.240, 
p=0.035 and OR=2.419, p=0.008, respectively), 
(Table 4). Rise in BMI for 1 kg/m2 enhanced the 
probability for higher blood pressure by 24%. 
Also, elevation in HOMA-IR for 1 unit, rose the 
probability for higher blood pressure almost 2.5 
times. In addition, even 47% of variation in 
blood pressure could be explained with this 
Model. Also, this Model correctly classified 76% 
of postmenopausal women having hypertension, 
170 
                                                                                                                                                               167
  
  
Vol 42   (2017)   br. 3                                                  Originalni rad 
 
www.tmg.org.rs 
 
 
which is of great importance concerning the fact 
that hypertension is often undiagnosed and 
untreated, leading to serious health 
consequences [14]. 
Furthermore, ROC analysis was used to 
discriminate postmenopausal women with 
hypertension from normotensive ones. When 
the Model tested in multivariate logistic 
regression analysis was used in ROC analysis, 
the clinical accuracy for diagnostic procedure 
was good (AUC=0.853). As well, this diagnostic 
procedure had sensitivity of 83.6% and 
specificity of 74.7% (Figure 1). 
Contradictory research results were observed 
when examining the independent role of obesity 
and/or insulin resistance on risk for 
hypertension. Namely, some studies reported 
independent relationship between obesity and 
hypertension incidence, acting through some 
other mechanisms, different from insulin 
signaling pathways [10, 11]. In line with this, 
Faria et al. [10] demonstrated the association 
between visceral fat and blood pressure, 
whereas No relationship between blood 
pressure levels and HOMA-IR was shown. 
Similar results were obtained from the study 
conducted by Lytsy et al. [15] in the cohort of 
middle-aged and elderly men, confirming that 
overweight/obesity without insulin resistance 
increases the risk of hypertension. 
On the other hand, our results are similar with 
the results of Ben Ali et al. [11], which reported 
the independent influence of both obesity and 
HOMA-IR on blood pressure in postmenopausal 
women. 
Insulin resistance as the link between obesity 
and hypertension is well established, since 
hyperinsulinemia may enhance sympathetic 
activity and sodium tubular reabsorption [8, 16].  
However, some other mechanisms, different 
from insulin signaling pathways have been also 
proposed to cause hypertension development 
[17, 18]. One possible mechanism lays in the 
explanation that sodium retention may result 
from disturbances in the kidney tissue, due to a 
compressive effect of the enlarged visceral fat 
[19]. This further results in an hyperactivity of 
the renin angiotensin system and consequent 
increase  in sodium reabsorption. This 
hypothesis is further supported by some studies 
which demonstrated a significant relationship 
between the amount of visceral fat and systolic 
blood pressure [10]. 
Furthermore, some studies suggest that the 
presence of a low-grade inflammation could 
predict the future onset of hypertension [9]. 
Lukic et al. [9] showed that increases in 
inflammation might be an important factor 
influencing the occurrence of hypertension in 
obese patients with diabetes, but which was 
associated with the rise in interleukin-6 (IL-6). 
Another pathogenic mechanism of hypertension 
onset may be attributed to the role of arterial 
stiffening which precedes the hypertension 
occurrence [20]. In this regard, it was suggested 
that low-grade inflammation may contribute to 
arterial stiffness, since the impairments in pulse 
wave velocity, a measure of large vessels 
distension ability, were correlated with the 
increases in circulating levels of IL-6 and tumor 
necrosis factor (TNF)-α [21, 22]. Furthermore, 
there are assumptions that pro-inflammatory 
cytokines may exert a direct pathogenic 
influence on vascular tone regulation leading to 
the hypertension development [23]. 
In our study, hypertensive postmenopausal 
women displayed higher level of inflammation 
(as measured with hsCRP), and it correlated well 
with both systolic and diastolic blood pressure 
in Spearman's non-parametric correlation 
analysis (Table 3). However, this association was 
dependent on both, BMI and HOMA-IR in our 
study (Table 4). 
Indeed, exogenous administration of TNF-α or 
IL-6 resulted in enhanced insulin resistance, 
suggesting that many cytokines may act in 
synchrony manner to induce this process [23]. In 
addition, enlarged adipose tissues is significant 
contributor of increased pro-inflammatory 
cytokines in circulation [4, 5, 8], thus further 
leading to decreased insulin sensitivity. 
A small sample size and cross-sectional design 
are some limitations of our study. However, our 
cohort comprised of normotensive and non-
treated hypertensive postmenopausal women, 
so we excluded medicines as confounding 
factors when estimating cardiometabolic profile 
of hypertensive group. Future longitudinal 
studies are needed to further explore 
patophysiological mechanisms related to 
hypertension onset and to find the best 
therapeutic target approach for its 
complications. 
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Conclusion 
Non-treated hypertensive postmenopausal 
women exerted unfavorable cardiometabolic 
profile, compared to normotensive counterparts. 
Both, body mass index and insulin resistance 
were the independent predictors of blood 
pressure in postmenopausal women. 
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